首页> 美国卫生研究院文献>PLoS Clinical Trials >Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice
【2h】

Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice

机译:PET成像技术的发展,以可视化异体来源的移植的iPSc衍生的心肌细胞中积累的活化的巨噬细胞,以检测小鼠的异体细胞移植的免疫排斥反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Allogeneic transplantation (Tx) of induced pluripotent stem cells (iPSCs) is a promising tissue regeneration therapy. However, this inevitably induces macrophage-mediated immune response against the graft, limiting its therapeutic efficacy. Monitoring the magnitude of the immune response using imaging tools would be useful for prolonging graft survival and increasing the therapy longevity. Minimally invasive quantitative detection of activated macrophages by medical imaging technologies such as positron emission tomography (PET) imaging targets translocator protein (TSPO), which is highly expressed on mitochondrial membrane, especially in activated macrophage. N,N-diethyl-2-[4-(2-fluoroethoxy) phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide (DPA-714) is known as a TSPO ligand used in clinical settings. We herein hypothesized that immune rejection of the transplanted iPSC-derived cardiomyocytes (iPSC-CMs) of allogeneic origin may be quantitated using 18F-DPA-714-PET imaging study. iPSC-CM cell-sheets of C57BL/6 mice origin were transplanted on the surface of the left ventricle (LV) of C57BL/6 mice as a syngeneic cell-transplant model (syngeneic Tx group), or Balb/c mice as an allogeneic model (allogeneic Tx group). 18F-DPA-714-PET was used to determine the uptake ratio, calculated as the maximum standardized uptake value in the anterior and septal wall of the LV. The uptake ratio was significantly higher in the allogeneic Tx group than in the syngeneic group or the sham group at days 7 and day 10 after the cell transplantation. In addition, the immunochemistry showed significant presence of CD68 and CD3-positive cells at day 7 and 10 in the transplanted graft of the allogeneic Tx group. The expression of TSPO, CD68, IL-1 beta, and MCP-1 was significantly higher in the allogeneic Tx group than in the syngeneic Tx and the sham groups at day 7. The 18F-DPA-714-PET imaging study enabled quantitative visualization of the macrophages-mediated immune rejection of the allogeneic iPSC-cardiac. This imaging tool may enable the understanding and monitoring host-immune response of the host, allogeneic cell transplantation therapy.
机译:诱导多能干细胞(iPSC)的同种异体移植(Tx)是一种有希望的组织再生疗法。然而,这不可避免地引起巨噬细胞介导的针对移植物的免疫反应,从而限制了其治疗功效。使用成像工具监测免疫反应的强度对于延长移植物存活和延长治疗寿命将是有用的。通过医学成像技术(例如正电子发射断层扫描(PET)成像)以微创定量检测活化的巨噬细胞靶向易位蛋白(TSPO),该蛋白在线粒体膜上高度表达,尤其是在活化的巨噬细胞中。 N,N-二乙基-2- [4-(2-氟乙氧基)苯基] -5,7-二甲基吡唑并[1,5-a]嘧啶-3-乙酰胺(DPA-714)是临床上使用的TSPO配体设置。我们在此假设,可以使用 18 F-DPA-714-PET成像研究定量对异体来源的移植的iPSC衍生的心肌细胞(iPSC-CM)的免疫排斥反应。将C57BL / 6小鼠来源的iPSC-CM细胞片移植为C57BL / 6小鼠的左心室(LV)表面,作为同基因细胞移植模型(同基因Tx组),或Balb / c小鼠作为同种异体移植模型模型(同种异体的Tx组)。使用 18 F-DPA-714-PET确定摄取率,计算为左室前壁和隔壁的最大标准化摄取值。细胞移植后第7天和第10天,同基因Tx组的摄取率显着高于同基因组或假组。另外,免疫化学显示在同种异体Tx组的移植移植物中,在第7天和第10天CD68和CD3阳性细胞显着存在。在第7天,异基因Tx组的TSPO,CD68,IL-1 beta和MCP-1的表达明显高于同基因Tx和假组。 18 F-DPA- 714-PET成像研究能够定量观察同种异体iPSC心脏巨噬细胞介导的免疫排斥反应。该成像工具可以实现了解和监测宿主的同种异体细胞移植治疗的宿主免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号